Neurofilament Light Chain (NfL) in Blood—A Biomarker Predicting Unfavourable Outcome in the Acute Phase and Improvement in the Late Phase after Stroke

Increased sensitivity of methods assessing the levels of neurofilament light chain (NfL), a neuron-specific intermediate filament protein, in human plasma or serum, has in recent years led to a number of studies addressing the utility of monitoring NfL in the blood of stroke patients. In this review...

Descripción completa

Detalles Bibliográficos
Autores principales: Pekny, Milos, Wilhelmsson, Ulrika, Stokowska, Anna, Tatlisumak, Turgut, Jood, Katarina, Pekna, Marcela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235722/
https://www.ncbi.nlm.nih.gov/pubmed/34207058
http://dx.doi.org/10.3390/cells10061537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235722/
https://www.ncbi.nlm.nih.gov/pubmed/34207058
http://dx.doi.org/10.3390/cells10061537

Ejemplares similares